Ownership

Raju Prasad

Insider Reports History

Entity: Individual
Location: Crispr Therapeutics, Inc., 105 W First Street, Boston, MA
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raju Prasad:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
CRISPR Therapeutics AG	Chief Financial Officer	Common Shares	6.48K	$471K	$72.69	Mar 15, 2024	Direct
CRISPR Therapeutics AG	Chief Financial Officer	Stock Option (Right to Buy)	18.3K			Oct 16, 2024	Direct
CRISPR Therapeutics AG	Chief Financial Officer	Restricted Stock Units	15K			Oct 16, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Raju Prasad

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CRSP	CRISPR Therapeutics AG	Oct 16, 2024	2	$0	4	Oct 18, 2024	Chief Financial Officer
CRSP	CRISPR Therapeutics AG	Mar 20, 2024	2	$0	4	Mar 22, 2024	Chief Financial Officer
CRSP	CRISPR Therapeutics AG	Mar 14, 2024	3	-$256K	4	Mar 18, 2024	Chief Financial Officer
CRSP	CRISPR Therapeutics AG	Oct 13, 2023	1	$0	4	Oct 17, 2023	Chief Financial Officer
CRSP	CRISPR Therapeutics AG	Mar 14, 2023	2	$0	4	Mar 14, 2023	Chief Financial Officer
CRSP	CRISPR Therapeutics AG	Mar 14, 2023	0	$0	3	Mar 14, 2023	Chief Financial Officer